Your browser doesn't support javascript.
loading
Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial.
Feig, Denice S; Sanchez, J Johanna; Murphy, Kellie E; Asztalos, Elizabeth; Zinman, Bernard; Simmons, David; Haqq, Andrea M; Fantus, I George; Lipscombe, Lorraine; Armson, Anthony; Barrett, Jon; Donovan, Lois; Karanicolas, Paul; Tobin, Siobhan; Mangoff, Kathryn; Klein, Gail; Jiang, Yidi; Tomlinson, George; Hamilton, Jill.
Affiliation
  • Feig DS; Department of Medicine, University of Toronto, Toronto, ON, Canada; Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada; Sinai Health System, Mount Sinai Hospital, Toronto, ON, Canada. Electronic address: d.feig@utoronto.ca.
  • Sanchez JJ; Sunnybrook Research Institute, Toronto, ON, Canada.
  • Murphy KE; Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada; Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada; Sinai Health System, Mount Sinai Hospital, Toronto, ON, Canada.
  • Asztalos E; Sunnybrook Research Institute, Toronto, ON, Canada; Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Zinman B; Department of Medicine, University of Toronto, Toronto, ON, Canada; Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada; Sinai Health System, Mount Sinai Hospital, Toronto, ON, Canada.
  • Simmons D; Department of Medicine, Western Sydney University, Sydney, NSW, Australia.
  • Haqq AM; Department of Pediatrics, University of Alberta, Edmonton, AB, Canada.
  • Fantus IG; Department of Medicine, University of Toronto, Toronto, ON, Canada; Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada; Sinai Health System, Mount Sinai Hospital, Toronto, ON, Canada; Department of Medicine and Research Institute, McGill University Health Center, McGill University, Montreal
  • Lipscombe L; Department of Medicine, University of Toronto, Toronto, ON, Canada; Department of Medicine, Women's College Hospital, Toronto, ON, Canada.
  • Armson A; Department of Obstetrics and Gynecology, Dalhousie University, Halifax, NS, Canada.
  • Barrett J; Sunnybrook Research Institute, Toronto, ON, Canada; Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Donovan L; Department of Medicine and Department of Obstetrics and Gynecology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Alberta Children's Hospital Research Institute, Calgary, AB, Canada.
  • Karanicolas P; Sunnybrook Research Institute, Toronto, ON, Canada; Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Tobin S; Sunnybrook Research Institute, Toronto, ON, Canada.
  • Mangoff K; Sunnybrook Research Institute, Toronto, ON, Canada.
  • Klein G; Sunnybrook Research Institute, Toronto, ON, Canada.
  • Jiang Y; Sunnybrook Research Institute, Toronto, ON, Canada.
  • Tomlinson G; Department of Medicine, University of Toronto, Toronto, ON, Canada; Department of Medicine, University Health Network, Toronto, ON, Canada.
  • Hamilton J; Department of Pediatrics, Division of Endocrinology, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Lancet Diabetes Endocrinol ; 11(3): 191-202, 2023 03.
Article de En | MEDLINE | ID: mdl-36746160
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / Metformine Type d'étude: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Child / Female / Humans / Infant / Pregnancy Pays/Région comme sujet: America do norte Langue: En Journal: Lancet Diabetes Endocrinol Année: 2023 Type de document: Article Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / Metformine Type d'étude: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Child / Female / Humans / Infant / Pregnancy Pays/Région comme sujet: America do norte Langue: En Journal: Lancet Diabetes Endocrinol Année: 2023 Type de document: Article Pays de publication: Royaume-Uni